National and Kapodistrian University of Athens
Εφαρμογή της πρωτεωμικής στην ανίχνευση ανωμαλιών των χρωμοσωμάτων του φύλου στο αμνιακό υγρό και το περιφερικό αίμα εγκύου
Abstract
dc:descriptionMedical advances in obstetrics and genetics provide the possibility of examination of the embryo for genetic abnormalities during gestation by use of techniques which have low but substantial risk for the pregnancy and the pregnant itself.Non invasive prenatal diagnosis techniques, mainly biochemical markers and ultrasonographic tests lack specificity, thus cannot be directly linked to a specific chromosomal abnormality, while they have a 5% chance of false positive result. Proteomic analysis (Proteomics) is a prominent new technology in the field of molecular medicine which, in combination with newly found sciences such as bioinformatics, has the potential to revolutionize the area of prenatal diagnostics. Examination methods that involve proteomic analysis are thought to drastically change the way diagnosis and treatment are performed in cases of many diseases. Proteomics focuses on the quantitative and qualitative analysis of the “proteome”, the sum of proteins of an organism at any given time, in order to investigate in deep biological functions and procedures.The present study involves the proteome analysis of amniotic fluid and plasma of 2nd trimester pregnancies in gestations of embryos with sex chromosomal abnormalities and the identification of biomarkers specific for each syndrome, in order to advance prognosis, diagnosis and treatment of each abnormality. Proteomic analysis was carried out by two dimensional gel electrophoresis and identification of protein spots was further performed by mass spectrometry. Proteins which were found to be differentially expressed between syndrome cases and control samples were further quantified by western blot analysis.Forty five amniotic fluid samples and 30 plasma samples of pregnant women in the 2nd trimester of pregnancy were analyzed in total:A. Fifteen amniotic fluid samples from pregnancies which was shown by routine cytogentic analysis that carried embryos with sex chromosome abnormalities, 6 were from Turner syndrome embyos (45, X0 caryotype), 5 from Klinefelter syndrome embryos (47, XXY caryotype) and 3 from 47, XXX caryotype.B. Thirty amniotic fluid samples from pregnancies with normal karyotype embryos. Fifteen normal male embryos (46, XY) and 15 with normal female embryos (46,XX), which were used as study controls.C. Ten plasma samples coming from pregnant carrying embryos with sex chromosomal abnormalities. Seven were pregnants carrying Turner syndrome embryos and 3 from pregnants carrying Klinefelter syndrome embryos.D. Twenty plasma samples from healthy uncomplicated 2nd trimester pregnancies that was known by routine cytogenetic analysis that carried normal karyotype embryos. 10 carrying healthy male embryos (46,XY) and 10 healthy female embryos (46,XX), that were used as study controls.As compared to controls, 7 proteins (TRFE, RETBP, LUM, APOA1, KNG, THBR, ApoA4) were found to be differentially expressed in amniotic fluid of Turner syndrome embryos, 7 proteins (CER, A1AT, ZA2G, APOA1, RETBP, GELS, VTDB) in amniotic fluid of Klinefelter syndrome embryos and 12 proteins (PAEP, VTDB, CYTC, AMBP, KAC, IBP1, CFAB, A1AT, TRFE, KNG, PRL, CSH) in amniotic fluid of 47, XXX embryos.Furthermore as compared to controls 16 proteins (CO3, HPT, SHBG, CD5L, HABP2, HBB, KAC, AFAM, C1S, A1BG, LAC, KNG, CLUS, IGHA1, IGJ, FIBG) were found to be differentially expressed in the plasma samples of pregnant women carrying Turner syndrome embryos and 5 proteins (FCN3, APOA4, APOE, APOH, TTR) in plasma samples of pregnats carrying Klinefelter syndrome embryos.This study, announces the dominant role of the proteomic technologies in the discovery of biomarkers concerning high risk pregnancies for chromosomal abnormalities. Even more it states the functionality of these techniques for the identification and study of proteins which are tightly correlated with the phenotypic characteristics of the sex chromosome abnormality syndromes.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Αναγνωστόπουλος, Αθανάσιος
- Anagnostopoulos, Athanasios
Subjects
dc:subject × 20- Πρωτεωμική
- Προγεννητικός έλεγχος
- Ανωμαλίες των χρωμοσωμάτων του φύλου
- Αμνιακό υγρό
- Περιφερικό αίμα
- Σύνδρομο Turner
- Σύνδρομο Klinefelter
- Σύνδρομο καρυότυπου 47, ΧΧΧ
- Proteomics
- Prenatal diagnosis
- Sex chromosome abnormalities
- Amniotic fluid
- Peripheral blood
- Turner syndrome
- Klinefelter syndrome
- 47, XXX karyotype
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29948